Rashtriya Newsflash

Oleoresin Market Size to Reach $2.54 Billion by 2031 as Demand for Clean-Label Extracts and Advanced Botanical Processing Gains Momentum – Mordor Intelligence

Oleoresin Market Size to Reach $2.54 Billion by 2031 as Demand for Clean-Label Extracts and Advanced Botanical Processing Gains Momentum – Mordor Intelligence

Oleoresin Market Size & Trends | Mordor Intelligence Mordor Intelligence has published a new report on the oleoresin market, offering a comprehensive analysis of market trends, growth drivers, competitive dynamics,

Read Full Article

Hyperphosphatemia Market Analysis 2036: Industry Trends, Market Size, and Emerging Therapeutic Developments – DelveInsight | Ardelyx, Sanofi, Takeda Pharma, Unicycive Therapeutics, Taisho Pharma

(Albany, New York) – September 22, 2026: The Key Hyperphosphatemia Companies in the market include – Ardelyx, Sanofi, Takeda Pharma, Unicycive Therapeutics, Taisho Pharma, Alebund Pharmaceuticals, FRESENIUS MEDICAL CARE RENAL

Read Full Article

Multiple Sclerosis Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Biogen, Immune Response BioPharma, Celgene, Novartis, Sanofi, Actelion, Baye

(Albany, New York) – September 22, 2026: (Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Multiple Sclerosis pipeline constitutes 75+ key companies continuously working towards developing 80+ Multiple

Read Full Article

Fabry Disease Market Growth Outlook 2036: Epidemiology, Pipeline Therapies, and Revenue Forecast – DelveInsight | Sanofi Genzyme, Sangamo Therapeutics, Freeline Therapeutics, AVROBIO, 4D Molecular

(Albany, New York) – September 22, 2026: The Key Fabry Disease Companies in the market include – Chiesi and Protalix Biotherapeutics, Sanofi Genzyme, Sangamo Therapeutics, Protalix Biotherapeutics, AVROBIO, Sanofi Genzyme,

Read Full Article

Chronic Insomnia Market Poised for Sustained Growth Amid Advancements in Treatment and Clinical Innovation by 2036 – DelveInsight | IDORSIA, EISAI, Janssen R&D, Takeda

(Albany, New York) – September 22, 2026: The Key Chronic Insomnia Companies in the market include – IDORSIA, EISAI, Janssen

Read Full Article

Diabetic Peripheral Neuropathy Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Helixmith, Lexicon Pharma, Glenmark Pharma, Praetego

(Albany, New York) – September 22, 2026: (Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Diabetic Peripheral Neuropathy

Read Full Article

Diffuse Large B-Cell Lymphoma Clinical Trials Drugs Development Pipeline Expands with Contributions from 70+ Key Companies | DelveInsight

The Diffuse Large B-Cell Lymphoma Clinical Trials analysis report delivers important insights into ongoing research of 70+ pipeline Diffuse Large

Read Full Article

Netherton Syndrome Clinical Trial Drug Development Pipeline Expands with Contributions from 4+ Key Companies | DelveInsight

The Netherton Syndrome Clinical Trials analysis report delivers important insights into ongoing research of 4+ pipeline Netherton Syndrome Drugs, clinical

Read Full Article

MRSA Infections Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 25+ Leading Players Wheeling the Therapeutics Landscape

The MRSA Infections Clinical Trials analysis report delivers important insights into ongoing research of 25+ pipeline MRSA Infections Drugs, clinical

Read Full Article

Bladder Cancer Clinical Trial Pipeline: Emerging Therapies and Key Developments Shaping the Treatment Landscape | DelveInsight

The Bladder Cancer clinical trial analysis report delivers important insights into ongoing research on 80+ pipeline Bladder Cancer Drugs, clinical

Read Full Article